Investigations into tropomyosin function using mouse models

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 5, 2010, Pages 893-898

  Jagatheesan, Ganapathy ^a   Rajan, Sudarsan ^a   Wieczorek, David F ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium sensitivity; Cardiac function; Sarcometic thin filament; Tropomyosin

Indexed keywords

ACTIN; ALPHA TROPOMYOSIN; BETA TROPOMYOSIN; GAMMA TROPOMYOSIN; TROPOMYOSIN; TROPONIN; TROPONIN T; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BINDING SITE; CALCIUM SIGNALING; GENE MUTATION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE RELAXATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE FUNCTION; MUTATIONAL ANALYSIS; MYOFILAMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SARCOMERE; SEQUENCE ALIGNMENT; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; CALCIUM; MICE; PROTEIN ISOFORMS; SARCOMERES; TROPOMYOSIN;

MUS; MUS MUSCULUS;

EID: 77951623501     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.10.003     Document Type: Review

References (44)

1. Lehman W., Craig R. Tropomyosin and the steric mechanism of muscle regulation. In: Tropomyosin (ed: P. Gunning). Adv Exp Med Biol 2008, 644:95-109.
2. Lehman W., Galinska-Rakocsy A., Hatch V., Tobacman L., Craig R. Structural basis for the activation of muscle contraction by troponin and tropomyosin. J Mol Biol 2009, 388:673-681.
3. 2+-dependent photocrosslinking of tropomyosin residue 146 to residues 157-163 in the c-terminal domain of troponin I in reconstituted skeletal muscle thin filaments. J Mol Biol 2009, 389:575-583.
4. Denz C.R., Narshi A., Zajdel R.W., Dube D.K. Expression of a novel cardiac-specific tropomyosin isoform in humans. Biochem Biophy Res Commun 2004, 320:1291-1297.
5. Rajan S., Jagatheesan G., Karam C.N., Alves M.L., Bodi I., Schwartz A., et al. Molecular and functional characterization of a novel cardiac specific human tropomyosin isoform. Circulation 2010, 121:410-418.
6. Muthuchamy M., Pajak L., Howles P., Doetschman T., Wieczorek D.F. Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol Cell Biol 1993, 13:3311-3323.
7. Rethinasamy P., Muthuchamy M., Hewett T., Boivin G., Wolska B.M., Evans C.R., et al. Molecular and physiological effects of α-tropomyosin ablation in the mouse. Circ Res 1998, 82:116-123.
8. Blanchard E.M., Iizuka K., Christe M., Conner D.A., Geisterfer-Lowrance A., Schoen F.J., et al. Targeted ablation of the murine alpha-tropomyosin gene. Circ Res 1997, 81:1005-1010.
9. Hook J., Lemckert F., Qin H., Schevzov G., Gunning P. Gamma tropomyosin gene products are required for embryonic development. Mol Cell Biol 2004, 24:2318-2323.
10. Lehman W., Hatch V., Korman V., Rosol M., Thomas L., Maytum R., et al. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol 2000, 302:593-606.
11. Muthuchamy M., Grupp I.L., Grupp G., O'Toole B.A., Kier A.B., Boivin G.P., et al. Molecular and physiological effects of overexpressing striated muscle b-tropomyosin in the adult murine heart. J Biol Chem 1995, 270:30593-30603.
12. 2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem 1996, 271:11611-11614.
13. Prabhakar R., Boivin G.P., Grupp I.L., Hoit B., Arteaga G., Solaro R.J., Wieczorek D.F. A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 2001, 33:1815-1828.
14. 2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin. Circ Res 1999, 84:745-751.
15. Clemmens E., Entezari M., Martyn D., Regnier M. Different effects of cardiac versus skeletal muscle regulatory proteins on in vitro measures of actin filament speed and force. J Physiol 2005, 566:737-746.
16. Pieples K., Wieczorek D.F. Tropomyosin 3 increases striated muscle isoform diversity. Biochem 2000, 39:8291-8297.
17. 2+ activation. Am J Physiol Heart Circ Physiol 2002, 283:H1344-H1353.
18. Singh A., Hitchcock-DeGregori S. A peek into tropomyosin binding and unfolding on the actin filament. PLoS ONE 2009, 4:e6336.
19. Sumida J., Wu E., Lehrer S. Conserved Asp-137 imparts flexibility to tropomyosin and affects function. J Biol Chem 2008, 283:6728-6734.
20. 2+ sensitivity and cooperativity. J Biol Chem 1983, 258:2534-2542.
21. Zot A.S., Potter J.D. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophy Biophy Chem 1987, 16:535-559.
22. Greenfield N.J., Palm T., Hitchcock-DeGregori S.E. Structure and interactions of the carboxyl terminus of striated muscle alpha-tropomyosin: it is important to be flexible. Biophys J 2002, 83:2754-2766.
23. Greenfield N.J., Huang Y.J., Swapna G.V., Bhattacharya A., Rapp B., Singh A., et al. Solution NMR structure of the junction between tropomyosin molecules: implications for actin binding and regulation. J Mol Biol 2006, 364:80-96.
24. Jagatheesan G., Rajan S., Petrashevskaya N., Schwartz, Boivin G., Vahebi S., et al. Functional importance of the carboxyl-terminal region of striated muscle tropomyosin. J Biol Chem 2003, 278:23204-23211.
25. 2+ sensitivity. Am J Physiol Heart Circ Physiol 2009, 297:H181-H190.
26. Jagatheesan G., Rajan S., Petrashevskaya N., Schwartz, Boivin G.P., Arteaga G.M., et al. Physiological significance of troponin T binding domains in striated muscle tropomyosin. Am J Physiol Heart Circ Physiol 2004, 287:H1484-H1494.
27. Mirza M., Marston S., Willott R., Ashley C., Mogensen J., McKenna W., et al. Dilated cardiomyopathy mutations in three thin filament regulatory proteins results in a common functional phenotype. J Biol Chem 2005, 280:28498-28506.
28. Rajan S., Ahmed R., Jagatheesan G., Petrashevskaya N., Boivin G., Urboniene D., et al. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 2007, 101:205-214.
29. Heller M., Nili M., Homsher E., Tobacman L. Cardiomyopathic tropomyosin mutations that increase thin filament Ca2+ sensitivity and tropomyosin N-domain flexibility. J Biol Chem 2003, 278:41742-41748.
30. Kee A.J., Hardeman E.C. Tropomyosins in skeletal muscle diseases. In: Tropomyosin (ed: P. Gunning). Adv Exp Med Biol 2008, 644:143-157.
31. Wieczorek D.F., Jagatheesan G., Rajan S. The role of tropomyosin in heart disease. In: Tropomyosin (ed: P. Gunning). Adv Exp Med Biol 2008, 644:132-142.
32. Tardiff J. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev 2005, 10:237-248.
33. Westfall M.V., Borton A.R., Albayya F.P., Metzger J.M. Myofilament calcium sensitivity and cardiac disease. Circ Res 2002, 91:525-531.
34. Muthuchamy M., Pieples K., Rethinasamy P., Hoit B., Grupp I.L., Boivin G.P., et al. Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction. Circ Res 1999, 85:47-56.
35. Prabhakar R., Petrashevskaya N., Schwartz A., Aronow B., Boivin G.P., Molkentin J.D., Wieczorek D.F. A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation. Mol Cell Biochem 2003, 251:33-42.
36. Evans C.C., Pena J.R., Phillips R.M., Muthuchamy M., Wieczorek D.F., Solaro R.J., Wolska B.M. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2000, 279:H2414-H2423.
37. Michele D.E., Gomez C.A., Hong K.E., Westfall M.V., Metzger J.M. Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by β-blockade. Circ Res 2002, 91:255-262.
38. Jagatheesan G., Rajan S., Petrashevskaya N., Schwartz, Boivin G.P., Arteaga G.M., Solaro R.J., et al. Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. Am J Physiol Heart Circ Physiol 2007, 293:H949-H958.
39. del Monte F., Hajjar R.J. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol 2003, 546:49-61.
40. Pena JR, Goldspink PH, Prabhakar R, del Monte F, Hajjar RJ, Wieczorek DF, et al. Neonatal gene transfer of SERCA2a improves the response to beta-adrenergic stimulation in a FHC alpha-tropomyosin (Glu180Gly) mouse model. Faseb J. 2004;18:A1216-A1217.
41. Pena JR, Goldspink PH, Heinrich LS, Kranias EG, Wieczorek DF, Wolska BM. Phospholamban Knockout Alters Hypertrophic Gene Expression and Improves Cardiac Function in a HCM alpha-Tropomyosin (Glu180Gly) Mouse. Circ Res 2008;103:E40.
42. Coutu P., Bennett C.N., Favre E.G., Day S.M., Metzger J.M. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ Res 2004, 94:1235-1241.
43. Sussman M.A., Lim H.W., Gude N., Taigen T., Olson E.N., Robbins J., et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998, 281:1690-1693.
44. Larkin M.A., Blackshields G., Brown N.P., Chednna R., McGettigan P.A., McWilliam H., et al. Clustal W and clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.